These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes. Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686 [TBL] [Abstract][Full Text] [Related]
24. Characterization and profiling of hepatic cytochromes P450 and phase II xenobiotic-metabolizing enzymes in beluga whales (Delphinapterus leucas) from the St. Lawrence River Estuary and the Canadian Arctic. McKinney MA; Arukwe A; De Guise S; Martineau D; Béland P; Dallaire A; Lair S; Lebeuf M; Letcher RJ Aquat Toxicol; 2004 Jul; 69(1):35-49. PubMed ID: 15210296 [TBL] [Abstract][Full Text] [Related]
25. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807 [TBL] [Abstract][Full Text] [Related]
26. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297 [TBL] [Abstract][Full Text] [Related]
28. Maturational development of drug-metabolizing enzymes in sheep. Kawalek JC; el Said KR Am J Vet Res; 1990 Nov; 51(11):1736-41. PubMed ID: 2240798 [TBL] [Abstract][Full Text] [Related]
29. Presence and inducibility by beta-naphthoflavone of CYP1A1, CYP1B1 and phase II enzymes in Trematomus bernacchii, an Antarctic fish. Di Bello D; Vaccaro E; Longo V; Regoli F; Nigro M; Benedetti M; Gervasi PG; Pretti C Aquat Toxicol; 2007 Aug; 84(1):19-26. PubMed ID: 17643506 [TBL] [Abstract][Full Text] [Related]
30. Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey. Longo V; Mazzaccaro A; Ventura P; Gervasi PG Xenobiotica; 1992 Apr; 22(4):427-31. PubMed ID: 1523863 [TBL] [Abstract][Full Text] [Related]
31. Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor. Kakizaki S; Yamazaki Y; Kosone T; Horiguchi N; Sohara N; Sato K; Takagi H; Yoshinari K; Mori M Liver Int; 2007 Feb; 27(1):109-19. PubMed ID: 17241389 [TBL] [Abstract][Full Text] [Related]
32. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Siest G; Jeannesson E; Marteau JB; Samara A; Marie B; Pfister M; Visvikis-Siest S Drug Metab Dispos; 2008 Jan; 36(1):182-9. PubMed ID: 17940135 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Achour B; Russell MR; Barber J; Rostami-Hodjegan A Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517 [TBL] [Abstract][Full Text] [Related]
34. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. McRobie DJ; Glover DD; Tracy TS Drug Metab Dispos; 1998 Apr; 26(4):367-71. PubMed ID: 9531526 [TBL] [Abstract][Full Text] [Related]
35. The effect of short-term alloxan-induced diabetes on the activity of drug metabolizing enzymes. Pachecka J; Kobylińska K; Suchocka Z; Kuczyńska J Acta Pol Pharm; 1993; 50(6):435-9. PubMed ID: 8067257 [TBL] [Abstract][Full Text] [Related]
36. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Shelby MK; Klaassen CD Drug Metab Dispos; 2006 Oct; 34(10):1772-8. PubMed ID: 16855052 [TBL] [Abstract][Full Text] [Related]
37. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821 [TBL] [Abstract][Full Text] [Related]
38. Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin. Berdikova Bohne VJ; Hamre K; Arukwe A Food Chem Toxicol; 2007 May; 45(5):733-46. PubMed ID: 17150295 [TBL] [Abstract][Full Text] [Related]
39. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. Chen G; Teicher BA; Frei E Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973 [TBL] [Abstract][Full Text] [Related]